Council of the European Union decisions on designer drugs

Today, Council of the European Union decisions on designer drugs is a topic that generates great interest and debate in society. With the passage of time, Council of the European Union decisions on designer drugs has acquired increasing relevance, influencing aspects both on a personal and global level. Since its emergence, Council of the European Union decisions on designer drugs has aroused the interest of academics, experts, and the general public, generating discussions around its implications, consequences, and possible solutions. In this article, we will thoroughly explore the Council of the European Union decisions on designer drugs phenomenon, analyzing its causes, effects, and possible solutions. We will also examine how Council of the European Union decisions on designer drugs has affected different aspects of our daily lives, and the future perspectives that are envisioned around this topic.

Council of the European Union decisions on designer drugs. Council of the European Union issued a set of decisions on 7 designer drugs to make them subject to control measures and criminal provisions.

List of substances

Decisions

Decisions based on Joint Action 97/396/JHA of 16 June 1997 adopted by the Council on the basis of Article K.3 of the Treaty on European Union, concerning the information exchange, risk assessment and the control of new synthetic drugs:

Decisions based on Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances:

Sources

See also